Personal tools
You are here: Home Peers Puzzled By Herberman's Stance On Cell Phones While Believers Rally
Navigation
Subscribe or renew subscription
Google Ad Links
 
Document Actions

Peers Puzzled By Herberman's Stance On Cell Phones While Believers Rally

A teaser for the Larry King Live news show July 29 got to the quintessence of the scientific controversy over cell phones:

“A prominent cancer researcher says, ‘Put down that phone right now, if you want to reduce the risk of cancer!’”

The researcher in the spotlight was none other than Ronald Herberman, a respected immunologist and founding director of the University of Pittsburgh Cancer Institute.

A week earlier, Herberman stunned his colleagues by sending out an e-mail blast to his cancer center’s 3,000 employees, urging them to limit their exposure to cell phones. This exploded into an international story: director of an NCI-designated cancer center sounds alarm over dangerous occupational exposure.
—By Paul Goldberg

Click on The Cancer Letter Archive at left to download the Aug. 1, 2008, issue (subscription required).
_____
tags:
Friday, August 01, 2008 in cancer preventionpolicy issues  | Permalink |  Comments (0)
del.icio.us   Digg   Yahoo   Google   Spurl
Log in


Forgot your password?
Top Headlines
« July 2010 »
Su Mo Tu We Th Fr Sa
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31
2010-07-02 00:00
00:00-00:00 Three Cooperative Groups To Combine Statistical Center Operations
2010-07-09 00:00
00:00-00:00 In Exit Interview, Niederhuber Says Clinical Trials System Must Refocus To Emphasize Translational Studies
2010-07-15 00:00
00:00-00:00 Harold Varmus Takes NCI Helm With No Promises, No Clichés
00:00-00:00 Prominent Duke Scientist Claimed Prizes He Didn't Win, Including Rhodes Scholarship
2010-07-23 00:00
12:00-12:00 Note to Cancer Letter Subscribers for Friday, July 23
14:40-14:40 The Potti Scandal: Biostatisticians Send Letter to Varmus, Lancet Oncology Expresses Concern
Categories:
FDA (16)
Medicare (4)
NCI (43)
cancer prevention (4)
cancer screening (19)
cancer treatment (16)
drug development (33)
legislation (6)
news makers (3)
oncology profession (12)
policy issues (31)
research funding (41)
Google Ads
 

Powered by Plone CMS, the Open Source Content Management System

This site conforms to the following standards: